Crescent Capital BDC, Inc. (NASDAQ:CCAP) Plans $0.42 Quarterly Dividend

Crescent Capital BDC, Inc. (NASDAQ:CCAP) declared a quarterly dividend on Thursday, February 20th, Wall Street Journal reports. Investors of record on Monday, March 31st will be given a dividend of 0.42 per share on Tuesday, April 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.12%. The ex-dividend date of this dividend is Monday, March 31st.

Crescent Capital BDC has increased its dividend payment by an average of 0.6% annually over the last three years. Crescent Capital BDC has a payout ratio of 88.0% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings fall.

Crescent Capital BDC Stock Performance

NASDAQ CCAP opened at $18.42 on Friday. Crescent Capital BDC has a 52-week low of $16.58 and a 52-week high of $20.19. The business’s 50-day moving average price is $19.43 and its 200 day moving average price is $18.87. The firm has a market cap of $682.50 million, a P/E ratio of 9.25 and a beta of 0.81. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.86%. The business had revenue of $46.40 million during the quarter, compared to analysts’ expectations of $47.27 million. On average, equities research analysts expect that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on CCAP. Keefe, Bruyette & Woods lifted their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 25th. Wells Fargo & Company cut their price objective on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Friday. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $19.17.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.